-
Our website is now a subscription based members only website. 95% of our website requires a minimum donation of $2/month or $12/year so we can keep this website going. Guests can only view about 5% of our website. Please register and donate $12 for a twelve month subscription. Thanks for your donation!
The RRDi is NOT selling anything on our website. The RRDi, a non profit organization, has affiliate relationships with Amazon, Arbonne, Demodex Solutions, and Dr. Tara O'Desky. When you click on an item in our shopping cart the RRDi receives a small fee if you purchase the item. You will be redirected either to Amazon, Demodex Solutions, Dr. Tara O'Desky or another affiliate web site to purchase the item. Please click on PURCHASE button. Thanks for supporting our non profit organization for rosacea sufferers! Choose either Amazon, Demodex Solutions or Dr. Tara O'Desky. Some of the items may link to Amazon and the item in our store is no longer available at Amazon. We apologize for any items that may no longer be available at Amazon. If you want to volunteer, please, let us know about this and contact us and volunteer. We sure could use the help. You can WRITE REVIEWS on any item in the store.
ISISPharma Metroruboril A.Z
1 Reduces redness within 4 weeks
2 Reduces inflammatory lesions (papules and pustules)
3 Improves cutaneous microcirculation
4 Hydrates and soothes
Product description
Redness and rosacea Anti-redness and rosacea care PROPERTIES 1 Reduces redness within 4 weeks 2 Reduces inflammatory lesions (papules and pustules) 3 Improves cutaneous microcirculation 4 Hydrates and soothes INGREDIENTS Azelaic acid (15%) Antibacterial / Antimicrobial / Anti-inflammatory ß-calm® complex Anti-redness / Soothing / Fortifying / Moisturising Glycerin (2%) Moisturising agent USE Morning and evening to clean skin. 0% Paraben . 0% Phenoxyethanol . Alcohol-free . Fragrance free TESTED UNDER DERMATOLOGICAL CONTROL CLINICALLY PROVEN EFFICACY PROTOCOL . Study carried out on 20 subjects presenting papulopustular rosacea on the face. . Application: twice a day during 56 days. . Clinical examination of the cutaneous state of the face by the dermatologist in charge of the study and counting of the inflammatory lesions. . Measurement of cutaneous color using Spectrocolorimeter®. . Measurement of the cutaneous microcirculation using TiVi600® on the face. . Photography of the full face using Visia®. CLINICAL RESULTS D0 D56 D0 D56 • Decrease in inflammatory lesions Papules -45% at Day 28 -60% at Day 56 Pustules -59% at Day 28 -88% at Day 56 • Decrease in redness -17% at Day 28 -18% at Day 56
Share
About ISISPharma Metroruboril A.Z
Purchase. About the product
1 Reduces redness within 4 weeks
2 Reduces inflammatory lesions (papules and pustules)
3 Improves cutaneous microcirculation
4 Hydrates and soothes
Product description
Redness and rosacea Anti-redness and rosacea care PROPERTIES 1 Reduces redness within 4 weeks 2 Reduces inflammatory lesions (papules and pustules) 3 Improves cutaneous microcirculation 4 Hydrates and soothes INGREDIENTS Azelaic acid (15%) Antibacterial / Antimicrobial / Anti-inflammatory ß-calm® complex Anti-redness / Soothing / Fortifying / Moisturising Glycerin (2%) Moisturising agent USE Morning and evening to clean skin. 0% Paraben . 0% Phenoxyethanol . Alcohol-free . Fragrance free TESTED UNDER DERMATOLOGICAL CONTROL CLINICALLY PROVEN EFFICACY PROTOCOL . Study carried out on 20 subjects presenting papulopustular rosacea on the face. . Application: twice a day during 56 days. . Clinical examination of the cutaneous state of the face by the dermatologist in charge of the study and counting of the inflammatory lesions. . Measurement of cutaneous color using Spectrocolorimeter®. . Measurement of the cutaneous microcirculation using TiVi600® on the face. . Photography of the full face using Visia®. CLINICAL RESULTS D0 D56 D0 D56 • Decrease in inflammatory lesions Papules -45% at Day 28 -60% at Day 56 Pustules -59% at Day 28 -88% at Day 56 • Decrease in redness -17% at Day 28 -18% at Day 56